TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Braxia Scientific ( (TSE:BRAX) ) has provided an announcement.
Braxia Scientific Corp. has faced significant financial and operational challenges, resulting in its failure to file necessary financial documents, leading to a cease trade order and the suspension of its shares on the Canadian Securities Exchange. The company has completed the sale of nearly all its assets, including the Canadian Rapid Treatment Center of Excellence Inc., leaving it with minimal resources and leading to the decision to wind down operations. The only remaining asset is the intellectual property related to the KetaMD platform, but it is unlikely to generate significant returns to cover existing liabilities.
More about Braxia Scientific
Braxia Scientific Corp. is a company that was involved in operating the Canadian Rapid Treatment Center of Excellence Inc., a wholly-owned subsidiary and clinic operator. The company was engaged in the healthcare industry, focusing on rapid treatment solutions.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $998.1K
See more data about BRAX stock on TipRanks’ Stock Analysis page.